However, these studies cultured hundreds of cells in stem cell medium (DMEM/F12+EGF+FGF2+B27); thus, it is not clear whether the enhanced CD133 originated from natural CD133+ cells or differentiated tumor cells. Here, PROM1 is linked to neoplasm.